Synapse - Mithat Gonen

Search Within

Mithat Gonen

Results (1028)

A selective approach to the resection of cystic lesions of the pancreas: Results from 539 consecutive patients

Journal Article

Allen, P. J.; D'Angelica, M.; Gonen, M.; Jaques, D. P.; Coit, D. G.; Jarnagin, W. R.; DeMatteo, R.; Fong, Y.; Blumgart, L. H.; Brennan, M. F.
Annals of Surgery (2006)

Fulltext@MSK | Save

Phase II trial of preoperative combined modality therapy for esophageal carcinoma: Induction cisplatin-irinotecan followed by concurrent cisplatinirinotecan and radiotherapy

Meeting Abstract

Tew, W. P.; Minsky, B.; Bains, M.; Rizk, N.; Rusch, V.; Kelsen, D. P.; Shah, M.; Kepler, S.; Gonen, M.; Ilson, D. H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Predicting non-sentinel node status after positive sentinel lymph node biopsy for breast cancer: Clinicians versus nomogram

Meeting Abstract

Specht, M.; Kattan, M. W.; Gonen, M.; Fey, J.; Van Zee, K. J.
Annals of Surgical Oncology (2005)

Fulltext@MSK | Save

Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer

Meeting Abstract

Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

FDG-PET scanning impacts management in selected patients with high-risk breast carcinoma

Meeting Abstract

Port, E. R.; Yeung, H.; Gonen, M.; Caravelli, J.; Liberman, L.; Borgen, P. I.; Larson, S.
Annals of Surgical Oncology (2005)

Fulltext@MSK | Save

Targeting antiapoptotic Bcl-2 family members with AT-101 in pre-clinical models of aggressive lymphoma in combination with cyclophosphamide (C) and rituximab (R) produces a marked improvement in therapeutic efficacy

Meeting Abstract

Paoluzzi, L.; Gonen, M.; Toner, L.; Smith, E.; Yang, D.; Holmund, J.; Sorensen, M.; O'connor, O.
Blood (2005)

Fulltext@MSK | Save

Phase I trial of hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone (DEX) in combination with systemic oxaliplatin (OXAL), fluorouracil (FU) plus loucovorin (LV) after resection of hepatic metastases from colorectal cancer

Meeting Abstract

Kemeny, N. E.; Jarnagin, W.; Gonen, M.; Haviland, D.; D'Angelica, M.; Blumgart, L.; DeMatteo, R.; Schwartz, L.; Fong, Y.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Decreased PET SUV after induction chemotherapy is associated with improved survival in malignant pleural mesothelioma (MPM)

Meeting Abstract

Flores, R. M.; Akhurst, T.; Krug, L.; Gonen, M.; Dycoco, J.; Rosenzweig, K.; Larson, S. M.; Downey, R. J.; Rusch, V. W.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Hepatic arterial infusion (HAI) therapy in patients with unresectable primary liver cancer: Use of dynamic contrast enhanced MRI to evaluate response

Meeting Abstract

Danso, M.; Jarnagin, W. R.; Muruganandham, M.; Schwartz, L. H.; Gonen, M.; Haviland, D.; Blumgart, L.; D'Angelica, M.; DeMatteo, R.; Kemeny, N.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients

Journal Article

Yeung, H. W. D.; Schoder, H.; Smith, A.; Gonen, M.; Larson, S. M.
Molecular Imaging and Biology (2005)

Fulltext@MSK | Save